Nicotine
Nicotine is a highly addictive stimulant found in tobacco and vaping products; it is the main reason tobacco use is so hard to quit, and it raises heart rate and blood pressure while carrying serious dependence and poisoning risks.
Overview
Nicotine is a naturally occurring stimulant found in tobacco and in the nightshade plant family, and it is the primary addictive ingredient in cigarettes, cigars, smokeless tobacco, and most vaping (e-cigarette) products. Most people who use tobacco do so regularly because they are addicted to nicotine. While nicotine itself drives addiction, much of the serious long-term harm of smoking comes from the many other chemicals in tobacco smoke; vaping devices deliver nicotine along with other chemicals and flavorings as an aerosol. Nicotine-replacement therapies (patches, gums, lozenges) deliver controlled doses of nicotine to help people stop smoking. Nicotine is legal and widely available, but its sale is regulated, including a federal minimum purchase age of 21 in the United States.
Source: NIDA; MedlinePlus; FDA
Chemistry & mechanism of action
Nicotine works by binding to nicotinic acetylcholine receptors in the brain. This triggers the release of several neurotransmitters, most importantly dopamine in the brain's reward circuits, producing a brief, mild pleasure and reinforcing repeated use. A short-lived surge of endorphins can cause a brief, slight euphoria, and nicotine can temporarily increase alertness, attention, and short-term memory while reducing appetite. Because the rewarding effect is brief, users tend to dose repeatedly throughout the day, which strongly reinforces dependence. Outside the brain, nicotine stimulates the cardiovascular system, increasing heart rate, blood pressure, and the heart's oxygen demand.
Source: NIDA; peer-reviewed pharmacology literature
Effects
Nicotine commonly produces a brief feeling of alertness, mild stimulation, and relaxation, along with reduced appetite. Some people feel a faster heartbeat or mild anxiety, nausea, or lightheadedness, especially when they are new to it or take a higher dose. Tolerance develops quickly, and regular users often feel that nicotine simply relieves the discomfort of withdrawal rather than producing a noticeable high. Withdrawal symptoms can begin within hours of the last use and include irritability, intense craving, anxiety, difficulty concentrating, restlessness, sleep problems, and increased appetite.
Source: NIDA; MedlinePlus
Risks & harms
Nicotine is highly addictive — this is its central risk, because addiction keeps people using tobacco products whose other components cause cancer, lung disease, heart attack, and stroke. Nicotine itself stresses the cardiovascular system by raising heart rate and blood pressure. It is genuinely dangerous to children and pets: concentrated liquid nicotine (e-cigarette refill fluid) can cause severe poisoning or death if swallowed, and even small amounts matter for a small body, so these products must be kept locked away. Nicotine exposure during pregnancy can harm fetal development, and adolescent use can affect the developing brain. Symptoms of nicotine poisoning include nausea, vomiting, rapid heartbeat, seizures, and difficulty breathing. If poisoning is suspected, contact Poison Control at 1-800-222-1222, or call 911 in an emergency. For help quitting, the SAMHSA helpline is 1-800-662-4357, and effective treatments exist, including nicotine-replacement therapy and prescription medications.
Source: NIDA; MedlinePlus; FDA
Legal status (US)
In the United States, nicotine and tobacco products are legal but regulated. The federal minimum age to purchase tobacco and nicotine products — including cigarettes, smokeless tobacco, and e-cigarettes — is 21. The U.S. Food and Drug Administration regulates the manufacture, marketing, and sale of tobacco and nicotine products, including which e-cigarette and flavored products may be legally sold, and that regulatory landscape continues to change. Some states and localities add further restrictions, such as bans on certain flavored products or limits on where these products may be used or sold. Nicotine-replacement therapies are sold over the counter or by prescription. Because rules differ by location and are evolving, check current state and local law. This is general legal information, not legal advice.
Source: FDA; US federal and state law
Drug laws and enforcement change and vary by country. This is not legal advice. Always confirm with the destination’s embassy or official drug authority before traveling — penalties can be severe, including imprisonment.
Before you travel
Verify current rules with the destination country’s official drug authorityand your own country’s embassy before traveling. Find the destination’s U.S. embassy & official country guidance →
Non-U.S. travelers: check your own government’s travel advisory and embassy.
If you’re detained or arrested abroad
Contact your own country’s embassy or consulatein the destination immediately — notthe destination’s authorities. U.S. citizens: contact the nearest U.S. embassy/consulate and the U.S. State Department at +1-202-501-4444 (from abroad). If a U.S. citizen is arrested or detained abroad →
Images
Visual references coming soon.
If it’s too intense
If an experience becomes overwhelming, the goal is to stay safe and let it pass — most difficult experiences ease as the drug wears off.
- Get to a calm, safe space with someone you trust who is sober and can stay with you.
- Cool down if you’re overheating — move somewhere cool, remove extra layers, rest. Overheating is especially a risk with stimulants and MDMA.
- Sip water to thirst — but don’t over-hydrate. Drinking large amounts of plain water (especially after MDMA) can dangerously dilute your blood sodium (hyponatremia). Electrolytes help more than volume.
- Slow your breathing — long, slow exhales help settle a racing heart and anxiety.
- A sugary drink, fruit juice, or a snack can ease shakiness and the anxiety that comes with low blood sugar.
- Do not take more, and do not add another substance to manage it. Redosing or adding something else (including a sedative like a benzodiazepine) can make things worse, not better.
With stimulants, overheating and a racing heart are the main concerns — get somewhere cool, stop any physical activity, and don't take more.
Source: general harm-reduction guidance from SAMHSA, NIH/NIDA, and MedlinePlus, in our own words. Draft — not yet medically reviewed.
Forensic dossier
Draft · every field is source-cited or marked “Unknown — pending review”Identity
- PubChem CID
- 89594PubChem PUG-REST ↗ · retrieved 2026-06-18
- IUPAC name
- 3-[(2S)-1-methylpyrrolidin-2-yl]pyridinePubChem PUG-REST ↗ · retrieved 2026-06-18
- Molecular formula
- C10H14N2PubChem PUG-REST ↗ · retrieved 2026-06-18
- SMILES
- CN1CCC[C@H]1C2=CN=CC=C2PubChem PUG-REST ↗ · retrieved 2026-06-18
- InChIKey
- SNICXCGAKADSCV-JTQLQIEISA-NPubChem PUG-REST ↗ · retrieved 2026-06-18
- Synonyms / aliases
- vape, L-Nicotine, (-)-Nicotine, (S)-Nicotine, (S)-(-)-Nicotine, Habitrol, Nicotrol, Nicoderm, Nicoderm Cq, Fumetobac, NicocidePubChem PUG-REST + seed aliases ↗ · retrieved 2026-06-18
Composition
- Composition
- N/A — single compound (see Identity)
Physical / pill characteristics
- Dosage form
- HUMAN OTC DRUGopenFDA drug label ↗ · retrieved 2026-06-18
- Shape
- Unknown — pending review (verify tablet imprint/shape against NLM Pillbox/DailyMed; N/A if not an oral tablet)
- Color
- Unknown — pending review (verify tablet imprint/shape against NLM Pillbox/DailyMed; N/A if not an oral tablet)
- Imprint
- Unknown — pending review (verify tablet imprint/shape against NLM Pillbox/DailyMed; N/A if not an oral tablet)
- Score
- Unknown — pending review (verify tablet imprint/shape against NLM Pillbox/DailyMed; N/A if not an oral tablet)
Scheduling & legal status
- US schedule
- Unknown — pending review
- International
- See EMCDDA/EUDA + WHO — synthesize per jurisdictionEMCDDA / EUDA ↗ · retrieved 2026-06-18
Effects
- Effects
- Cited source pending synthesis — author in our words from NIDA/MedlinePlus on review (NOT auto-generated)NIDA + MedlinePlus ↗ · retrieved 2026-06-18
Risks
- Risks
- Cited source pending synthesis — author in our words from NIDA/MedlinePlus on review (NOT auto-generated)NIDA + MedlinePlus ↗ · retrieved 2026-06-18
Interactions
- Interactions
- See DailyMed label §Drug Interactions (Rx) — synthesize + cite per itemDailyMed SPL §Drug Interactions ↗ · retrieved 2026-06-18
Dosage
Pending medical reviewer
